{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1381699994554110464.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Nozomi Niitsu"}],"foaf:familyName":[{"@value":"Niitsu"}],"foaf:givenName":[{"@value":"Nozomi"}]}],"career":[{"institution":{"notation":[{"@value":"From the First Department of Internal Medicine, Toho University School of Medicine, Tokyo; Research Institute, Saitama Cancer Center, Saitama; the Department of Internal Medicine, Fujita Health University School of Medicine, Toyoake; Hematology-Oncology Division, Chiba Cancer Center Hospital, Chiba; Toyama Prefectural Central Hospital, Toyama; and the First Department of Internal Medicine, Niigata University School of Medicine, Niigata, Japan."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1361699994554110464","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1182/blood.v97.5.1202"},{"@type":"URI","@value":"http://ashpublications.org/blood/article-pdf/97/5/1202/1671769/1202.pdf"},{"@type":"PMID","@value":"11222361"},{"@type":"NAID","@value":"30022492925"}],"notation":[{"@value":"Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1182/blood.v97.5.1202_WzWa7kVz7NXw94tFxa7CslliIw7"},{"@type":"OPENAIRE","@value":"doi_dedup___::31933878f929df6f8bb802a341d7bc60_WzWa7kVz7NXw94tFxa7CslliIw7"}]}